Lactate, as a subproduct of glycolysis, contributes to enhancing CD133 levels in hepatocellular cancer [40], oral squamous cell carcinoma [41] and colorectal carcinoma cells [42]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.